Table 3
Co-existence of IBS, gastro-oesophageal reflux symptoms and BHR
Observed prevalence (95% CI)
Expected prevalence (95% CI)
Male
1.65% (1.57–1.73)
0.41% (0.39–0.43)
Female
3.20% (3.05–3.35)
0.94% (0.90–0.98)
Total
2.49% (2.41–2.57)
0.68% (0.66–0.71)
CI, confidence interval.